Moderna, Merck Show Progress Toward Cancer Vaccines

[ad_1] An mRNA shot helped prevent relapse in high-risk melanoma patients. [ad_2] Source link

Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study

[ad_1] Business Health Care Health The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said [ad_2] Source link